{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:14:50Z","timestamp":1791515690892,"version":"4.3.4"},"reference-count":56,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T00:00:00Z","timestamp":1536364800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.celrep.2018.09.012","type":"journal-article","created":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T10:42:21Z","timestamp":1538476941000},"page":"80-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":115,"title":["The Kinase Activity of Hematopoietic Progenitor Kinase 1 Is Essential for the Regulation of T Cell Function"],"prefix":"10.1016","volume":"25","author":[{"given":"Sairy","family":"Hernandez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Qing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca Hong","family":"Thibodeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangnan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Summer","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyang-Mi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soyoung","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meron","family":"Roose-Girma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soren","family":"Warming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Nannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Sampath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong M.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane L.","family":"Grogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira","family":"Mellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2018.09.012_bib1","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1158\/1078-0432.CCR-12-2199","article-title":"PD-L1 on tumor cells is induced in ascites and promotes peritoneal dissemination of ovarian cancer through CTL dysfunction","volume":"19","author":"Abiko","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2018.09.012_bib2","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1038\/bjc.2015.101","article-title":"IFN-\u03b3 from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer","volume":"112","author":"Abiko","year":"2015","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.celrep.2018.09.012_bib3","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1084\/jem.160.2.521","article-title":"Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence","volume":"160","author":"Ahmed","year":"1984","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2018.09.012_bib4","doi-asserted-by":"crossref","first-page":"6187","DOI":"10.4049\/jimmunol.0802631","article-title":"Hematopoietic progenitor kinase 1 is a negative regulator of dendritic cell activation","volume":"182","author":"Alzabin","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2018.09.012_bib5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00262-009-0761-0","article-title":"Hematopoietic progenitor kinase 1 is a critical component of prostaglandin E2-mediated suppression of the anti-tumor immune response","volume":"59","author":"Alzabin","year":"2010","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.celrep.2018.09.012_bib6","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1411087","article-title":"PD-1 blockade with nivolumab in relapsed or refractory Hodgkin\u2019s lymphoma","volume":"372","author":"Ansell","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2018.09.012_bib7","doi-asserted-by":"crossref","first-page":"14675","DOI":"10.1074\/jbc.M008343200","article-title":"Caspase-mediated cleavage of hematopoietic progenitor kinase 1 (HPK1) converts an activator of NFkappaB into an inhibitor of NFkappaB","volume":"276","author":"Arnold","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2018.09.012_bib8","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1128\/MCB.25.6.2364-2383.2005","article-title":"Activation of hematopoietic progenitor kinase 1 involves relocation, autophosphorylation, and transphosphorylation by protein kinase D1","volume":"25","author":"Arnold","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.celrep.2018.09.012_bib9","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/sj.cdd.4402042","article-title":"Sustained JNK signaling by proteolytically processed HPK1 mediates IL-3 independent survival during monocytic differentiation","volume":"14","author":"Arnold","year":"2007","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.celrep.2018.09.012_bib10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/35003228","article-title":"Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b","volume":"403","author":"Bachmaier","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2018.09.012_bib11","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T\u00a0cells during chronic viral infection","volume":"439","author":"Barber","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2018.09.012_bib12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12916-015-0455-8","article-title":"Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis","volume":"13","author":"Bertrand","year":"2015","journal-title":"BMC Med."},{"key":"10.1016\/j.celrep.2018.09.012_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ni.1679","article-title":"Coregulation of CD8+ T\u00a0cell exhaustion by multiple inhibitory receptors during chronic viral infection","volume":"10","author":"Blackburn","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2018.09.012_bib14","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1038\/sj.emboj.7600894","article-title":"Activation or suppression of NFkappaB by HPK1 determines sensitivity to activation-induced cell death","volume":"24","author":"Brenner","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.celrep.2018.09.012_bib15","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1182\/blood-2007-01-071167","article-title":"Caspase-cleaved HPK1 induces CD95L-independent activation-induced cell death in T and B lymphocytes","volume":"110","author":"Brenner","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2018.09.012_bib16","doi-asserted-by":"crossref","first-page":"14508","DOI":"10.1073\/pnas.0900457106","article-title":"Phosphorylation of CARMA1 by HPK1 is critical for NF-kappaB activation in T\u00a0cells","volume":"106","author":"Brenner","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2018.09.012_bib17","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1126\/science.1116221","article-title":"Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis","volume":"310","author":"Castellone","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.celrep.2018.09.012_bib18","doi-asserted-by":"crossref","first-page":"238ra70","DOI":"10.1126\/scitranslmed.3008211","article-title":"Improved survival with T\u00a0cell clonotype stability after anti-CTLA-4 treatment in cancer patients","volume":"6","author":"Cha","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2018.09.012_bib19","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2018.09.012_bib20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nm.3831","article-title":"Prostaglandin E2 and programmed cell death 1 signaling coordinately impair CTL function and survival during chronic viral infection","volume":"21","author":"Chen","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2018.09.012_bib21","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/35003235","article-title":"Cbl-b regulates the CD28 dependence of T-cell activation","volume":"403","author":"Chiang","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2018.09.012_bib22","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.4049\/jimmunol.135.2.1172","article-title":"Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expression","volume":"135","author":"Chouaib","year":"1985","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2018.09.012_bib23","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.immuni.2016.01.024","article-title":"MAP kinase inhibition promotes T\u00a0cell and anti-tumor activity in combination with PD-L1 checkpoint blockade","volume":"44","author":"Ebert","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2018.09.012_bib24","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/S0140-6736(16)00587-0","article-title":"Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial","volume":"387","author":"Fehrenbacher","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.celrep.2018.09.012_bib25","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1084\/jem.187.9.1383","article-title":"Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes","volume":"187","author":"Gallimore","year":"1998","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2018.09.012_bib26","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/nm1114","article-title":"TCR affinity and negative regulation limit autoimmunity","volume":"10","author":"Gronski","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2018.09.012_bib27","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2018.09.012_bib28","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1101\/gad.10.18.2251","article-title":"Human HPK1, a novel human hematopoietic progenitor kinase that activates the JNK\/SAPK kinase cascade","volume":"10","author":"Hu","year":"1996","journal-title":"Genes Dev."},{"key":"10.1016\/j.celrep.2018.09.012_bib29","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.immuni.2004.07.013","article-title":"Essential role of the E3 ubiquitin ligase Cbl-b in T\u00a0cell anergy induction","volume":"21","author":"Jeon","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2018.09.012_bib30","doi-asserted-by":"crossref","first-page":"7013","DOI":"10.1002\/j.1460-2075.1996.tb01093.x","article-title":"HPK1, a hematopoietic protein kinase activating the SAPK\/JNK pathway","volume":"15","author":"Kiefer","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.celrep.2018.09.012_bib31","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1083\/jcb.201103105","article-title":"Release of serine\/threonine-phosphorylated adaptors from signaling microclusters down-regulates T\u00a0cell activation","volume":"195","author":"Lasserre","year":"2011","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.celrep.2018.09.012_bib32","doi-asserted-by":"crossref","first-page":"14572","DOI":"10.1038\/ncomms14572","article-title":"Tumour and host cell PD-L1 is required to mediate suppression of anti-tumour immunity in mice","volume":"8","author":"Lau","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2018.09.012_bib33","doi-asserted-by":"crossref","first-page":"18908","DOI":"10.1074\/jbc.M101485200","article-title":"Involvement of hematopoietic progenitor kinase 1 in T\u00a0cell receptor signaling","volume":"276","author":"Ling","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2018.09.012_bib34","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S1074-7613(00)80192-2","article-title":"HPK1 is activated by lymphocyte antigen receptors and negatively regulates AP-1","volume":"12","author":"Liou","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2018.09.012_bib35","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.1038\/sj.onc.1204771","article-title":"The role of Gads in hematopoietic cell signalling","volume":"20","author":"Liu","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.celrep.2018.09.012_bib36","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/sj.onc.1204224","article-title":"Leukocyte-specific adaptor protein Grap2 interacts with hematopoietic progenitor kinase 1 (HPK1) to activate JNK signaling pathway in T lymphocytes","volume":"20","author":"Ma","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.celrep.2018.09.012_bib37","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature10673","article-title":"Cancer immunotherapy comes of age","volume":"480","author":"Mellman","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2018.09.012_bib38","doi-asserted-by":"crossref","first-page":"e0170396","DOI":"10.1371\/journal.pone.0170396","article-title":"Serine phosphorylation of SLP76 is dispensable for T\u00a0cell development but modulates helper T\u00a0cell function","volume":"12","author":"Navas","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.celrep.2018.09.012_bib39","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1002\/eji.201040313","article-title":"HPK1 competes with ADAP for SLP-76 binding and via Rap1 negatively affects T-cell adhesion","volume":"40","author":"Patzak","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.celrep.2018.09.012_bib40","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.4049\/jimmunol.1490019","article-title":"IL-2: the first effective immunotherapy for human cancer","volume":"192","author":"Rosenberg","year":"2014","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2018.09.012_bib41","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0140-6736(16)00561-4","article-title":"Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial","volume":"387","author":"Rosenberg","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.celrep.2018.09.012_bib42","doi-asserted-by":"crossref","first-page":"45207","DOI":"10.1074\/jbc.M106811200","article-title":"Hematopoietic progenitor kinase 1 associates physically and functionally with the adaptor proteins B cell linker protein and SLP-76 in lymphocytes","volume":"276","author":"Sauer","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2018.09.012_bib43","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1182\/blood-2002-07-2316","article-title":"Hematopoietic progenitor kinase 1 (HPK1) negatively regulates prostaglandin E2-induced fos gene transcription","volume":"101","author":"Sawasdikosol","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2018.09.012_bib44","doi-asserted-by":"crossref","first-page":"34693","DOI":"10.1074\/jbc.M707425200","article-title":"Prostaglandin E2 activates HPK1 kinase activity via a PKA-dependent pathway","volume":"282","author":"Sawasdikosol","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2018.09.012_bib45","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/S1359-6446(02)02391-7","article-title":"Novel chemical genetic approaches to the discovery of signal transduction inhibitors","volume":"7","author":"Shokat","year":"2002","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.celrep.2018.09.012_bib46","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/ni1416","article-title":"Hematopoietic progenitor kinase 1 negatively regulates T\u00a0cell receptor signaling and T\u00a0cell-mediated immune responses","volume":"8","author":"Shui","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2018.09.012_bib47","doi-asserted-by":"crossref","first-page":"200ra116","DOI":"10.1126\/scitranslmed.3006504","article-title":"Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T\u00a0cells","volume":"5","author":"Spranger","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"2 Pt A","key":"10.1016\/j.celrep.2018.09.012_bib48","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.molimm.2015.02.009","article-title":"Current state of anti-PD-L1 and anti-PD-1 agents in cancer therapy","volume":"67","author":"Swaika","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.celrep.2018.09.012_bib49","doi-asserted-by":"crossref","first-page":"127ra37","DOI":"10.1126\/scitranslmed.3003689","article-title":"Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape","volume":"4","author":"Taube","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2018.09.012_bib50","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/1074-7613(95)90125-6","article-title":"Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4","volume":"3","author":"Tivol","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2018.09.012_bib51","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00109-014-1133-6","article-title":"The actin-myosin regulatory MRCK kinases: regulation, biological functions and associations with human cancer","volume":"92","author":"Unbekandt","year":"2014","journal-title":"J.\u00a0Mol. Med. (Berl.)"},{"key":"10.1016\/j.celrep.2018.09.012_bib52","doi-asserted-by":"crossref","first-page":"6913","DOI":"10.1128\/MCB.02255-05","article-title":"Zfp423 is required for normal cerebellar development","volume":"26","author":"Warming","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.celrep.2018.09.012_bib53","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1126\/science.270.5238.985","article-title":"Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4","volume":"270","author":"Waterhouse","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.celrep.2018.09.012_bib54","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","article-title":"Molecular signature of CD8+ T\u00a0cell exhaustion during chronic viral infection","volume":"27","author":"Wherry","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2018.09.012_bib55","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1084\/jem.188.12.2205","article-title":"Viral immune evasion due to persistence of activated T\u00a0cells without effector function","volume":"188","author":"Zajac","year":"1998","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2018.09.012_bib56","doi-asserted-by":"crossref","first-page":"328rv4","DOI":"10.1126\/scitranslmed.aad7118","article-title":"PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations","volume":"8","author":"Zou","year":"2016","journal-title":"Sci. Transl. Med."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124718314426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124718314426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T10:28:26Z","timestamp":1761906506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124718314426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S2211124718314426"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2018.09.012","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Kinase Activity of Hematopoietic Progenitor Kinase 1 Is Essential for the Regulation of T Cell Function","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2018.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}